Sympathetic Nervous System Dysfunction in Multiple Sclerosis, Linking Neurodegeneration to a Reduced Response to Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|12|1635-1644

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.12, 2012-01, pp. : 1635-1644

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neurodegeneration in multiple sclerosis

By  

PHARMAKON, Vol. 2, Iss. 6, 2014-11 ,pp. : 388-394

Govi-Verlag

Access to resources Recommend Favorite

Neurodegeneration and Neuroprotection in Multiple Sclerosis

By  

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. : 4471-4474

Bentham Science Publishers

Access to resources Recommend Favorite

Inflammation in the central nervous system in multiple sclerosis: The role of chemokines and their receptors

By Simpson Julie E.   Woodroofe M. Nicola  

Inflammopharmacology, Vol. 9, Iss. 1-2, 2001-05 ,pp. : 23-33

VSP

Access to resources Recommend Favorite

Polyphenols, Antioxidants and the Sympathetic Nervous System

By  

Current Pharmaceutical Design, Vol. 24, Iss. 2, 2018-04 ,pp. : 130-139

Bentham Science Publishers

Access to resources Recommend Favorite

Optical Coherence Tomography Detection of Neurodegeneration in Multiple Sclerosis

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 5, 2012-08 ,pp. : 518-527

Bentham Science Publishers

Access to resources Recommend Favorite